APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Propofol Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025190 pages

Choose your research edition.

Industry ResearchPropofol Drug Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Drug Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Propofol Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Drug Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Propofol Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Propofol Drug include Xi’an Libang Pharmaceutical, Sichuan Kelun Pharmaceutical, Jiangsu Yingke Biopharmaceutical, Guangdong Jiabo Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Beijing Sciecure Pharmaceutical, Sichuan Biokin Pharmaceutical, Wellona Pharma and Rusoma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol Drug Segment by Company

Xi’an Libang Pharmaceutical

Sichuan Kelun Pharmaceutical

Jiangsu Yingke Biopharmaceutical

Guangdong Jiabo Pharmaceutical

Jiangsu Nhwa Pharmaceutical

Beijing Sciecure Pharmaceutical

Sichuan Biokin Pharmaceutical

Wellona Pharma

Rusoma

Pfizer

NEON

Fresenius Kabi

Flagship Biotech

Dr. Reddy's Laboratories

Centurion Healthcare

B. Braun

Aspen Pharma

Propofol Drug Segment by Type

50 mL

20 mL

100 mL

10 mL

Propofol Drug Segment by Application

Mechanical Ventilation

General Anesthesia

Medical Procedures Sedation

Other

Propofol Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Propofol Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Propofol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Propofol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Propofol Drug Industry Trends Table 2. Propofol Drug Industry Drivers Table 3. Propofol Drug Industry Opportunities and Challenges Table 4. Propofol Drug Industry Restraints Table 5. Global Propofol Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Propofol Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Propofol Drug Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Propofol Drug Sales Market Share by Manufacturers Table 9. Global Propofol Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Propofol Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Propofol Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Propofol Drug Manufacturers, Product Type & Application Table 13. Global Propofol Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50 mL Table 17. Major Manufacturers of 20 mL Table 18. Major Manufacturers of 100 mL Table 19. Major Manufacturers of 10 mL Table 20. Global Propofol Drug Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Propofol Drug Sales by Type (2021-2026) & (M Units) Table 22. Global Propofol Drug Sales by Type (2027-2032) & (M Units) Table 23. Global Propofol Drug Sales Market Share by Type (2021-2026) Table 24. Global Propofol Drug Sales Market Share by Type (2027-2032) Table 25. Global Propofol Drug Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 26. Global Propofol Drug Revenue by Type (2021-2026) & (M Units) Table 27. Global Propofol Drug Revenue by Type (2027-2032) & (M Units) Table 28. Global Propofol Drug Revenue Market Share by Type (2021-2026) Table 29. Global Propofol Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Mechanical Ventilation Table 31. Major Manufacturers of General Anesthesia Table 32. Major Manufacturers of Medical Procedures Sedation Table 33. Major Manufacturers of Other Table 34. Global Propofol Drug Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 35. Global Propofol Drug Sales by Application (2021-2026) & (M Units) Table 36. Global Propofol Drug Sales by Application (2027-2032) & (M Units) Table 37. Global Propofol Drug Sales Market Share by Application (2021-2026) Table 38. Global Propofol Drug Sales Market Share by Application (2027-2032) Table 39. Global Propofol Drug Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 40. Global Propofol Drug Revenue by Application (2021-2026) & (M Units) Table 41. Global Propofol Drug Revenue by Application (2027-2032) & (M Units) Table 42. Global Propofol Drug Revenue Market Share by Application (2021-2026) Table 43. Global Propofol Drug Revenue Market Share by Application (2027-2032) Table 44. Global Propofol Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 45. Global Propofol Drug Sales by Region (2021-2026) & (M Units) Table 46. Global Propofol Drug Sales Market Share by Region (2021-2026) Table 47. Global Propofol Drug Sales Forecasted by Region (2027-2032) & (M Units) Table 48. Global Propofol Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Propofol Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. North America Propofol Drug Sales by Country (2021-2026) & (M Units) Table 51. North America Propofol Drug Sales by Country (2027-2032) & (M Units) Table 52. Europe Propofol Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Europe Propofol Drug Sales by Country (2021-2026) & (M Units) Table 54. Europe Propofol Drug Sales by Country (2027-2032) & (M Units) Table 55. Asia Pacific Propofol Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Asia Pacific Propofol Drug Sales by Country (2021-2026) & (M Units) Table 57. Asia Pacific Propofol Drug Sales by Country (2027-2032) & (M Units) Table 58. South America, Middle East and Africa Propofol Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. South America, Middle East and Africa Propofol Drug Sales by Country (2021-2026) & (M Units) Table 60. South America, Middle East and Africa Propofol Drug Sales by Country (2027-2032) & (M Units) Table 61. Global Propofol Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Propofol Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Propofol Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Propofol Drug Revenue Market Share by Region (2021-2026) Table 65. Global Propofol Drug Revenue Market Share by Region (2027-2032) Table 66. Xi’an Libang Pharmaceutical Company Information Table 67. Xi’an Libang Pharmaceutical Business Overview Table 68. Xi’an Libang Pharmaceutical Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Xi’an Libang Pharmaceutical Propofol Drug Product Portfolio Table 70. Xi’an Libang Pharmaceutical Recent Development Table 71. Sichuan Kelun Pharmaceutical Company Information Table 72. Sichuan Kelun Pharmaceutical Business Overview Table 73. Sichuan Kelun Pharmaceutical Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sichuan Kelun Pharmaceutical Propofol Drug Product Portfolio Table 75. Sichuan Kelun Pharmaceutical Recent Development Table 76. Jiangsu Yingke Biopharmaceutical Company Information Table 77. Jiangsu Yingke Biopharmaceutical Business Overview Table 78. Jiangsu Yingke Biopharmaceutical Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Jiangsu Yingke Biopharmaceutical Propofol Drug Product Portfolio Table 80. Jiangsu Yingke Biopharmaceutical Recent Development Table 81. Guangdong Jiabo Pharmaceutical Company Information Table 82. Guangdong Jiabo Pharmaceutical Business Overview Table 83. Guangdong Jiabo Pharmaceutical Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Guangdong Jiabo Pharmaceutical Propofol Drug Product Portfolio Table 85. Guangdong Jiabo Pharmaceutical Recent Development Table 86. Jiangsu Nhwa Pharmaceutical Company Information Table 87. Jiangsu Nhwa Pharmaceutical Business Overview Table 88. Jiangsu Nhwa Pharmaceutical Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Jiangsu Nhwa Pharmaceutical Propofol Drug Product Portfolio Table 90. Jiangsu Nhwa Pharmaceutical Recent Development Table 91. Beijing Sciecure Pharmaceutical Company Information Table 92. Beijing Sciecure Pharmaceutical Business Overview Table 93. Beijing Sciecure Pharmaceutical Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Beijing Sciecure Pharmaceutical Propofol Drug Product Portfolio Table 95. Beijing Sciecure Pharmaceutical Recent Development Table 96. Sichuan Biokin Pharmaceutical Company Information Table 97. Sichuan Biokin Pharmaceutical Business Overview Table 98. Sichuan Biokin Pharmaceutical Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Sichuan Biokin Pharmaceutical Propofol Drug Product Portfolio Table 100. Sichuan Biokin Pharmaceutical Recent Development Table 101. Wellona Pharma Company Information Table 102. Wellona Pharma Business Overview Table 103. Wellona Pharma Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Wellona Pharma Propofol Drug Product Portfolio Table 105. Wellona Pharma Recent Development Table 106. Rusoma Company Information Table 107. Rusoma Business Overview Table 108. Rusoma Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Rusoma Propofol Drug Product Portfolio Table 110. Rusoma Recent Development Table 111. Pfizer Company Information Table 112. Pfizer Business Overview Table 113. Pfizer Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Pfizer Propofol Drug Product Portfolio Table 115. Pfizer Recent Development Table 116. NEON Company Information Table 117. NEON Business Overview Table 118. NEON Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. NEON Propofol Drug Product Portfolio Table 120. NEON Recent Development Table 121. Fresenius Kabi Company Information Table 122. Fresenius Kabi Business Overview Table 123. Fresenius Kabi Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Fresenius Kabi Propofol Drug Product Portfolio Table 125. Fresenius Kabi Recent Development Table 126. Flagship Biotech Company Information Table 127. Flagship Biotech Business Overview Table 128. Flagship Biotech Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Flagship Biotech Propofol Drug Product Portfolio Table 130. Flagship Biotech Recent Development Table 131. Dr. Reddy's Laboratories Company Information Table 132. Dr. Reddy's Laboratories Business Overview Table 133. Dr. Reddy's Laboratories Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Dr. Reddy's Laboratories Propofol Drug Product Portfolio Table 135. Dr. Reddy's Laboratories Recent Development Table 136. Centurion Healthcare Company Information Table 137. Centurion Healthcare Business Overview Table 138. Centurion Healthcare Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Centurion Healthcare Propofol Drug Product Portfolio Table 140. Centurion Healthcare Recent Development Table 141. B. Braun Company Information Table 142. B. Braun Business Overview Table 143. B. Braun Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. B. Braun Propofol Drug Product Portfolio Table 145. B. Braun Recent Development Table 146. Aspen Pharma Company Information Table 147. Aspen Pharma Business Overview Table 148. Aspen Pharma Propofol Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Aspen Pharma Propofol Drug Product Portfolio Table 150. Aspen Pharma Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Propofol Drug Distributors List Table 154. Propofol Drug Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Propofol Drug Product Image Figure 2. Global Propofol Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Propofol Drug Sales (2021-2032) & (M Units) Figure 5. Global Propofol Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Propofol Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50 mL Image Figure 9. 20 mL Image Figure 10. 100 mL Image Figure 11. 10 mL Image Figure 12. Global Propofol Drug Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Propofol Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Propofol Drug Sales Market Share by Type (2021-2032) Figure 15. Global Propofol Drug Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 16. Global Propofol Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Propofol Drug Revenue Market Share by Type (2021-2032) Figure 18. Mechanical Ventilation Image Figure 19. General Anesthesia Image Figure 20. Medical Procedures Sedation Image Figure 21. Other Image Figure 22. Global Propofol Drug Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Propofol Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Propofol Drug Sales Market Share by Application (2021-2032) Figure 25. Global Propofol Drug Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 26. Global Propofol Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Propofol Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 29. North America Propofol Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Canada Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Mexico Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 33. Europe Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Europe Propofol Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 36. France Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 37. U.K. Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Italy Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Netherlands Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Asia Pacific Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Asia Pacific Propofol Drug Sales Market Share by Country (2021-2032) Figure 42. China Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Japan Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 44. South Korea Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 45. Southeast Asia Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 46. India Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 47. Australia Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South America, Middle East and Africa Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 49. South America, Middle East and Africa Propofol Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 51. South Africa Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Saudi Arabia Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Turkey Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Argentina Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 55. UAE Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Egypt Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Chile Propofol Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 58. Global Propofol Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Propofol Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Propofol Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Propofol Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Propofol Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Propofol Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Propofol Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Propofol Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Propofol Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Propofol Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Propofol Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Propofol Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mL
  • 20 mL
  • 100 mL
  • 10 mL
Applications
  • Mechanical Ventilation
  • General Anesthesia
  • Medical Procedures Sedation
  • Other
Companies covered
  • Xi’an Libang Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Jiangsu Yingke Biopharmaceutical
  • Guangdong Jiabo Pharmaceutical
  • Jiangsu Nhwa Pharmaceutical
  • Beijing Sciecure Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • Wellona Pharma
  • Rusoma
  • Pfizer
  • NEON
  • Fresenius Kabi
  • Flagship Biotech
  • Dr. Reddy's Laboratories
  • Centurion Healthcare
  • B. Braun
  • Aspen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Propofol Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Propofol Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Propofol Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Propofol Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Propofol Drug Market Dynamics
  1. 2.1 Propofol Drug Industry Trends
  2. 2.2 Propofol Drug Industry Drivers
  3. 2.3 Propofol Drug Industry Opportunities and Challenges
  4. 2.4 Propofol Drug Industry Restraints
3 Propofol Drug Market by Manufacturers
  1. 3.1 Global Propofol Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Propofol Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Propofol Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Propofol Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Propofol Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Propofol Drug Manufacturers, Product Type & Application
  7. 3.7 Global Propofol Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Propofol Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Propofol Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Propofol Drug Tier 1, Tier 2, and Tier 3
4 Propofol Drug Market by Type
  1. 4.1 Propofol Drug Type Introduction
  2. 4.1.1 50 mL
  3. 4.1.2 20 mL
  4. 4.1.3 100 mL
  5. 4.1.4 10 mL
  6. 4.2 Global Propofol Drug Sales by Type
  7. 4.2.1 Global Propofol Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Propofol Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Propofol Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Propofol Drug Revenue by Type
  11. 4.3.1 Global Propofol Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Propofol Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Propofol Drug Revenue Market Share by Type (2021-2032)
5 Propofol Drug Market by Application
  1. 5.1 Propofol Drug Application Introduction
  2. 5.1.1 Mechanical Ventilation
  3. 5.1.2 General Anesthesia
  4. 5.1.3 Medical Procedures Sedation
  5. 5.1.4 Other
  6. 5.2 Global Propofol Drug Sales by Application
  7. 5.2.1 Global Propofol Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Propofol Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Propofol Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Propofol Drug Revenue by Application
  11. 5.3.1 Global Propofol Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Propofol Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Propofol Drug Revenue Market Share by Application (2021-2032)
6 Global Propofol Drug Sales by Region
  1. 6.1 Global Propofol Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Propofol Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Propofol Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Propofol Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Propofol Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Propofol Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Propofol Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Propofol Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Propofol Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Propofol Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Propofol Drug Revenue by Region
  1. 7.1 Global Propofol Drug Revenue by Region
  2. 7.1.1 Global Propofol Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Propofol Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Propofol Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Propofol Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Propofol Drug Revenue (2021-2032)
  8. 7.2.2 North America Propofol Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Propofol Drug Revenue (2021-2032)
  11. 7.3.2 Europe Propofol Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Propofol Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Propofol Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Propofol Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Propofol Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Xi’an Libang Pharmaceutical
  2. 8.1.1 Xi’an Libang Pharmaceutical Company Information
  3. 8.1.2 Xi’an Libang Pharmaceutical Business Overview
  4. 8.1.3 Xi’an Libang Pharmaceutical Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Xi’an Libang Pharmaceutical Propofol Drug Product Portfolio
  6. 8.1.5 Xi’an Libang Pharmaceutical Recent Developments
  7. 8.2 Sichuan Kelun Pharmaceutical
  8. 8.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 8.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Kelun Pharmaceutical Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Kelun Pharmaceutical Propofol Drug Product Portfolio
  12. 8.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 8.3 Jiangsu Yingke Biopharmaceutical
  14. 8.3.1 Jiangsu Yingke Biopharmaceutical Company Information
  15. 8.3.2 Jiangsu Yingke Biopharmaceutical Business Overview
  16. 8.3.3 Jiangsu Yingke Biopharmaceutical Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Yingke Biopharmaceutical Propofol Drug Product Portfolio
  18. 8.3.5 Jiangsu Yingke Biopharmaceutical Recent Developments
  19. 8.4 Guangdong Jiabo Pharmaceutical
  20. 8.4.1 Guangdong Jiabo Pharmaceutical Company Information
  21. 8.4.2 Guangdong Jiabo Pharmaceutical Business Overview
  22. 8.4.3 Guangdong Jiabo Pharmaceutical Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Guangdong Jiabo Pharmaceutical Propofol Drug Product Portfolio
  24. 8.4.5 Guangdong Jiabo Pharmaceutical Recent Developments
  25. 8.5 Jiangsu Nhwa Pharmaceutical
  26. 8.5.1 Jiangsu Nhwa Pharmaceutical Company Information
  27. 8.5.2 Jiangsu Nhwa Pharmaceutical Business Overview
  28. 8.5.3 Jiangsu Nhwa Pharmaceutical Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Nhwa Pharmaceutical Propofol Drug Product Portfolio
  30. 8.5.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  31. 8.6 Beijing Sciecure Pharmaceutical
  32. 8.6.1 Beijing Sciecure Pharmaceutical Company Information
  33. 8.6.2 Beijing Sciecure Pharmaceutical Business Overview
  34. 8.6.3 Beijing Sciecure Pharmaceutical Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Sciecure Pharmaceutical Propofol Drug Product Portfolio
  36. 8.6.5 Beijing Sciecure Pharmaceutical Recent Developments
  37. 8.7 Sichuan Biokin Pharmaceutical
  38. 8.7.1 Sichuan Biokin Pharmaceutical Company Information
  39. 8.7.2 Sichuan Biokin Pharmaceutical Business Overview
  40. 8.7.3 Sichuan Biokin Pharmaceutical Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sichuan Biokin Pharmaceutical Propofol Drug Product Portfolio
  42. 8.7.5 Sichuan Biokin Pharmaceutical Recent Developments
  43. 8.8 Wellona Pharma
  44. 8.8.1 Wellona Pharma Company Information
  45. 8.8.2 Wellona Pharma Business Overview
  46. 8.8.3 Wellona Pharma Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Wellona Pharma Propofol Drug Product Portfolio
  48. 8.8.5 Wellona Pharma Recent Developments
  49. 8.9 Rusoma
  50. 8.9.1 Rusoma Company Information
  51. 8.9.2 Rusoma Business Overview
  52. 8.9.3 Rusoma Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Rusoma Propofol Drug Product Portfolio
  54. 8.9.5 Rusoma Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Propofol Drug Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 NEON
  62. 8.11.1 NEON Company Information
  63. 8.11.2 NEON Business Overview
  64. 8.11.3 NEON Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NEON Propofol Drug Product Portfolio
  66. 8.11.5 NEON Recent Developments
  67. 8.12 Fresenius Kabi
  68. 8.12.1 Fresenius Kabi Company Information
  69. 8.12.2 Fresenius Kabi Business Overview
  70. 8.12.3 Fresenius Kabi Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fresenius Kabi Propofol Drug Product Portfolio
  72. 8.12.5 Fresenius Kabi Recent Developments
  73. 8.13 Flagship Biotech
  74. 8.13.1 Flagship Biotech Company Information
  75. 8.13.2 Flagship Biotech Business Overview
  76. 8.13.3 Flagship Biotech Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Flagship Biotech Propofol Drug Product Portfolio
  78. 8.13.5 Flagship Biotech Recent Developments
  79. 8.14 Dr. Reddy's Laboratories
  80. 8.14.1 Dr. Reddy's Laboratories Company Information
  81. 8.14.2 Dr. Reddy's Laboratories Business Overview
  82. 8.14.3 Dr. Reddy's Laboratories Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Dr. Reddy's Laboratories Propofol Drug Product Portfolio
  84. 8.14.5 Dr. Reddy's Laboratories Recent Developments
  85. 8.15 Centurion Healthcare
  86. 8.15.1 Centurion Healthcare Company Information
  87. 8.15.2 Centurion Healthcare Business Overview
  88. 8.15.3 Centurion Healthcare Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Centurion Healthcare Propofol Drug Product Portfolio
  90. 8.15.5 Centurion Healthcare Recent Developments
  91. 8.16 B. Braun
  92. 8.16.1 B. Braun Company Information
  93. 8.16.2 B. Braun Business Overview
  94. 8.16.3 B. Braun Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 B. Braun Propofol Drug Product Portfolio
  96. 8.16.5 B. Braun Recent Developments
  97. 8.17 Aspen Pharma
  98. 8.17.1 Aspen Pharma Company Information
  99. 8.17.2 Aspen Pharma Business Overview
  100. 8.17.3 Aspen Pharma Propofol Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Aspen Pharma Propofol Drug Product Portfolio
  102. 8.17.5 Aspen Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol Drug Value Chain Analysis
  2. 9.1.1 Propofol Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol Drug Production Mode & Process
  6. 9.2 Propofol Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol Drug Distributors
  9. 9.2.3 Propofol Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst